Coronavirus personalised risk modelsCOVID-19 Datasets Viewer
Clinical Studies
Metadata of the studies included in the viewer.
| Publication reference | URL of Dataset | Clinical Trial ID | Country | Country code | Study design | Total number of subjects | Ethnicity | Existent variables | Exclusion criteria | Inclusion criteria | Demographic | Clinical variables | Laboratory variables | Comorbidities | Drugs | Imaging | Endpoint | Type of data |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://doi.org/10.1101/2020.07.07.20148304 | NaN | NaN | USA | USA | Cross-sectional | 3927 | NaN | Demographic|Clinical|Laboratory|Comorbidities | NaN | NaN | Age|Sex | Heart Rate|Oxygen Saturation|Temperature | Alanine aminotransferase|Aspartate aminotransferase|Blood glucose|Blood urea nitrogen|C-Reactive protein|Creatinine|Hemoglobin|Corpuscular volume|Platelet count|Potassium|Prothrombin time|Sodium|White blood cell count | Cardiac dysrhythmias|Chronic kidney disease|Heart disease|Diabetes | NaN | NaN | NaN | Structured |
| NaN | NaN | NaN | USA | USA | Cross-sectional | 3661 | NaN | Demographic|Clinical|Laboratory|Imaging | NaN | Chest X-ray images linked to radiology reports & encounter information|Discharged patients|Chest X-rays collected prior to any adverse events|Non-intubated based on manual annotation | Age|BMI | Heart Rate|Respiratory rate|Temperature|Systolic blood pressure|Diastolic blood pressure|Oxygen Saturation | Albumin|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Blood urea nitrogen|Calcium|Chloride|Creatinine|D-Dimer|Eosinophil count|Eosinophil percentage|Hematocrit|Lactate dehydrogenase|Lymphocyte percentage|Lymphocyte count|Platelet volume|Neutrophil count|Neutrophil percentage|Platelet count|Potassium|Procalcitonin|Total protein|Sodium|Troponin level | NaN | NaN | X ray | NaN | Mixed |
| https://doi.org/10.1101/2020.04.26.20073411 | NaN | NaN | USA | USA | Cross-sectional | 3055 | Non-Hispanic|Latino|Hispanic|Latino|Unknown | Demographic|Clinical|Laboratory|Comorbidities | NaN | Inpatient|Age greater than 18|Positive result or RT-PCR SARS CoV-2 lab test|COVID 19 lab order less than equal to 48 hr after admit|Incubation time less than equal to 48 hr from admit|Death time after admit time | Age|Sex | Heart Rate|Pulse|Respiration Rate|Temperature|Systolic blood pressure|Diastolic blood pressure | Sodium|Potassium|Creatinine|Lactate|White blood cell count|Lymphocyte percentage|Hemoglobin|Red blood cell distribution width|Platelet count|Alanine aminotransferase|Aspartate aminotransferase|Albumin|Total bilirubin|Prothrombin time|Partial Prothrombin time|PCO2|pH|C-Reactive protein|Ferritin|D-Dimer|Creatinine phosphokinase|Lactate dehydrogenase|Troponin level | Hypertension|Atrial fibrillation|Coronary artery disease|Heart failure|Stroke|Chronic kidney disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Cancer | NaN | NaN | NaN | Structured |
| https://doi.org/10.1101/2020.04.23.20076737 | NaN | NCT04280705 | USA | USA | Observational | 217 | White|Black|Asian|Other|Unknown | Demographic|Laboratory|Drugs|Comorbidities | NaN | NaN | Age|Sex|BMI | ICU days|Hospital days|Ventilator days|Vassopressor days | D-Dimer|C-Reactive protein|PaO2/FiO2 | Hypertension|Congestive heart failure|Coronary artery disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Chronic kidney disease/ end stage renal disease| | Hydroxychloroquine|Remdesivir | NaN | NaN | NaN |
| https://doi.org/10.1016/S0140-6736(20)31189-2 | NaN | NaN | USA | USA | Longitudinal | 257 | Black or African American|Hispanic or Latino|White|Asian|Other | Demographic|Clinical|Laboratory|Comorbidities|Drugs | NaN | NaN | Age|Sex|BMI | Temperature|Heart Rate|Respiratory rate|Systolic blood pressure|Oxygen Saturation|Altered mental status | Lactate|Creatinine|Proteinuria|Urine protein concentration|White blood cell count|Lymphocyte count|Platelet count|Bilirubin|Aspartate aminotransferase|Alanine aminotransferase|Creatine kinase|Prothrombin time|Interleukin-6|High-sensitivity C-Reactive protein|Ferritin|D-Dimer|High-sensitivity Troponin|Procalcitonin | Hypertension|Diabetes|Chronic Cardiac arrest (excluding hypertension)|Chronic kidney disease|Current or former smoker|Chronic obstructive pulmonary disease or interstitial Lung disease|Chronic neurological disease or dementia|Asthma|Active solid or haematological malignancy or dysplasia|Solid organ Transplantion recipient|HIV|Liver cirrhosis | Hydroxychloroquine|Remdesivir | NaN | NaN | Structured |
| https://doi.org/10.1136/bmj.m1996 | NaN | NaN | USA | USA | Observational | 1000 | Asian|Black or African American|Hispanic or Latino|Not specified|Other|White | Demographic|Comorbidities|Drugs | NaN | NaN | Age|Sex|BMI | NaN | NaN | Hypertension|Diabetes|Coronary artery disease|Congestive heart failure|Pulmonary disease|Asthma|Chronic obstructive pulmonary disease|Obstructive sleep apnea|Interstitial Lung disease|Renal disease|History of stroke|Active cancer|Transplantion history|Rheumatalogic disease|HIV|Viral hepatitis|Cirrhosis|Obesity | ACEi|NSAIDs|Statinss|Diuretics|Inotropes|Vasopressors|Intravenous immunoglobulin|Steroidss|Hydroxychloroquine|Tocilizumab|Remdesivir|Lopinavir/Ritonavir|Azithromycin|Ceftriaxone|Doxycycline|Levofloxacin|Meropenem|Piperacillin/tazobactum|Vancomycin|Other antibiotics | NaN | NaN | Unstructured |
| https://doi.org/10.1002/ejhf.1924 | NaN | NaN | UK | GBR | Interventional | 12000 | Caucasian|Black|Asian|Unknown|Mixed|Other | Demographic|Laboratory|Comorbidities|Drugs | NaN | Admission of symptomatic patients | Age|Sex|BMI | NaN | Systolic blood pressure|Diastolic blood pressure | Hypertension|Diabetes|Heart failure|Ischaemic Heart Disease|Chronic obstructive pulmonary disease|Asthma|Chronic kidney disease|Previous stroke/TIA | ACEi|ARB|Statins|Beta-blocker | NaN | Death|Critical Care|Alive | NaN |
| https://doi.org/10.1101/2020.03.21.20040691 | NaN | NCT04275245 | China | CHN | Interventional | 39 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.04.06.20054890 | NaN | NaN | China | CHN | Observational | 97 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Structured |
| https://doi.org/10.1016/j.jinf.2020.03.002 | NaN | NaN | China | CHN | Interventional | 33 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Structured |
| https://doi.org/10.1101/2020.04.08.20057539 | NaN | NaN | China | CHN | Observational | 564 | NaN | Demographic|Laboratory|Comorbidities|Drugs|Imaging | Without available clinical or imaging data|Age less than 18 years | NaN | Age|Sex | NaN | Hemoglobin|Platelet count|Neutrophil count|Leukocyte count|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Albumin|Blood urea nitrogen|Creatinine|Sodium|Potassium|Creatine kinase|Lactose dehydrogenase|D-Dimer|Procalcitonin|C-Reactive protein|Abnormal CT findings|Lung CT score | Hypertension|Diabetes|Cardiovascular disease|Chronic obstructive pulmonary disease|Cerebrovascular disease|Chronic renal disease|Hepatitis B/C|Malignancy|Immunodeficiency | Arbidol|Lopinavir/Ritonavir|Interferon-α | CT scan | Severe pneumonia | NaN |
| https://doi.org/10.1056/NEJMoa2007016 | NaN | NaN | USA|Europe|Japan | USA|JPN | Interventional | 61 | NaN | Demographic|Laboratory|Comorbidities|Drugs| | NaN | NaN | Age|Sex | NaN | Alanine aminotransferase|Aspartate aminotransferase|Creatinine | Any condition|Hypertension|Diabetes|Hyperlipidemia|Asthma | Remdesivir | NaN | Death|Critical Care|Alive | Structured |
| https://doi.org/10.1101/2020.04.01.20048561 | NaN | NCT04322188 | Italy | ITA | Interventional | 30 | NaN | Demographic|Laboratory|Comorbidities|Drugs| | NaN | NaN | Age|Sex|Height|Weight | NaN | White blood cell count|Hemoglobin|Platelet count|Lymphocyte count|Monocyte count|Neutrophil count|Alanine aminotransferase|Aspartate aminotransferase|Creatinine|Procalcitonin|Lactate dehydrogenase|Interleukin-6|C-Reactive protein | Hypertension|Diabetes|Cardiovascular disease|Malignancy|Cerebrovascular disease|Chronic kidney disease | Siltuximab | NaN | Reduces morality associated with COVID 19 and respiratory failure | Structured |
| https://doi.org/10.1101/2020.03.25.20037721 | NaN | NaN | China | CHN | Interventional | 323 | NaN | Demographic|Laboratory|Comorbidities|Drugs|Imaging | NaN | NaN | Age|BMI|Sex|Temperature|Hypnotics|Smoking history|Drinking | NaN | White blood cell count|Neutrophil count|Lymphocyte count|Platelet count|C-Reactive protein|Serum Amyloid A|Hypersensitive troponin|Prothrombin time|Creatine kinase|Lactate dehydrogenase|Alanine aminotransferase|Aspartate aminotransferase|Blood urea nitrogen|Creatinine|Glucose|RT-PCR | Cirrhosis|Hypertension|Diabetes|Malignancy|Cerebrovascular disease|Chronic obstructive pulmonary disease|Chronic kidney disease|Chronic liver disease|Cardiovascular and cerebrovascular diseases|Digestive system disease|Endocrine system disease|Nervous system disease|Respiratory disease | Oseltamivir|Ganciclovir|Arbidol|Kaletra|Interferon-α|Antibiotics|CorticoSteroids/glucocorticoid | CT scan | NaN | Structured |
| https://doi.org/10.1101/2020.04.11.20061473 | NaN | NCT04320238 | China | CHN | Interventional | 2944 | NaN | Dermographic|Drugs | NaN | Official members of Taihe Hospital Medical staff | Age|Sex | NaN | NaN | NaN | Interferon-α|Thymosin-α1 | NaN | NaN | Structured |
| https://doi.org/10.1101/2020.04.15.20067017 | NaN | NaN | Brazil | BRA | Interventional | 27 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | NaN | Age|Sex | NaN | D-Dimer|Lactate dehydrogenase|Platelet count|PaO2/FiO2 | Breast cancer|Atrial fibrillation|Obesity|Hypertension|Chronic obstructive pulmonary disease|Parkinson disease|Diabetes|Coronary heart disease|Hyperthyrodisim|Asthma|Cerebrovascular disease|Treated lymphoma|Tobacco dependence | Heparin | NaN | Discharged | NaN |
| https://doi.org/10.1101/2020.04.22.20075671 | NaN | NaN | USA | USA|JPN | Interventional | 490 | Hispanic|Non Hispanic|Unknown | Demographic|Comorbidities|Drugs|Imaging | NaN | Inpatients with COVID 19|Inpatients with COVID 19 administered with AZ and/or HCQ|Patients with greater than 2 ECGs | Age|Sex|BMI | NaN | NaN | Heart failure|Hypertension|Diabetes|Chronic kidney disease|Chronic obstructive pulmonary disease | Azithromycin|Hydroxychloroquine | ECG | NaN | Structured |
| https://doi.org/10.1002/jmv.25893 | NaN | NaN | China | CHN | Interventional | 184 | NaN | Demographic|Laboratory|Drugs|Imaging | NaN | NaN | Age|Sex | NaN | Alanine aminotransferase|Aspartate aminotransferase|Leukocyte count|Neutrophil count|Lymphocyte count|Erythrocyte sedimentation rate | NaN | Arbidol|Lopinavir/Ritonavir|Interferon-α|Darunavir | CT scan | NaN | Structured |
| https://doi.org/10.1101/2020.03.28.20046144 | NaN | chiCTR2000030700 | China | CHN | Observational | 42 | NaN | Demographic|Laboratory|Comorbidities|Drugs | Patients received glucocorticoids|Patients received immunepreparations|Patients with chronic infectious diseases|Patients had no cytokine test|Patients with liver and kidney insufficiency|Patients received Low Molecular Weight Heparin (LMWH) in the previous three months | NaN | Age|Sex | NaN | Respiratory rate|Pulse|Systolic blood pressure | Hypertension|Diabetes|Cardiovascular disease|Chronic obstructive Lung disease|Carcinoma|Chronic kidney disease | Arbidol|Recombinant human Interferon-α2B (aeresol inhalation)|Ribavirin|Lopinavir/Ritonavir|Traditional medicine|Heparin | NaN | NaN | Structured |
| https://doi.org/10.1101/2020.04.21.20066258 | NaN | NaN | China | CHN | Interventional | 115 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | Patients diagnosed with COVID 19|Corticosteriod therapy | Age|Sex | NaN | White blood cell count|Lymphocyte count|Serum potassium|Creatinine|Lactate dehydrogenase|Serum Amyloid A|C-Reactive protein|Erythrocyte sedimentation rate|Creatine kinase|Albumin|D-Dimer| | Hypertension|Cardiovascular disease|Diabetes | Corticosteriod | NaN | NaN | Structured |
| https://doi.org/10.1101/2020.03.06.20032342 | NaN | NaN | China | CHN | Interventional | 46 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging | NaN | NaN | Age|Sex | Temperature|Heart Rate|Systolic pressure|Diastolic blood pressure|Respiratory rate|SpO2 at rest | White blood cell count|Lymphocyte count|Neutrophil count|C-Reactive protein|Procalcitonin|Interleukin-2|Interleukin-4|Interleukin-6|Interleukin-10|Ferroprotein | Chronic Cardiac arrest|Chronic obstructive pulmonary disease|Cerebrovascular disease|Malignancy|Diabetes|Hypertension | Methylprednisolone | CT scan | NaN | Structured |
| https://doi.org/10.1089/scd.2020.0080 | NaN | NaN | USA | USA | Observational | 24 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | Age between 18 and 85 years|Positive result on SARS-CoV-2 polymerase chain reaction (PCR)|Presentation of fever and/or dyspnea for greater than 72 h|Overall clinicaldeterioration as evidenced by downtrending PaO2/FiO2 | Age|Sex|BMI|Weight|Height | NaN | PaO2/FiO2 | Hypertension|Hyperlipidemia | ExoFlo | NaN | Recovered|Crticical Care | Structured |
| https://doi.org/10.1016/j.eng.2020.03.007 | NaN | ChiCTR2000029600 | China | NaN | Observational | 91 | NaN | Demographic|Laboratory|Comorbidities|Drugs|Imaging | NaN | Age between 16 and 75 years old|Nasopharyngeal swabs samples tested positive for the novel coronavirus|Duration from disease onset to enrolment less than 7 days|Willing to take contraception during the study and within 7days after treatment|No difficulty in swalloing the pills. | Age|Sex|BMI | NaN | White blood cell count|Neutrophil count|Lymphocyte count|Alanine aminotransferase|Aspartate aminotransferase|Gamma glutamyl transpeptidase|C-Reactive protein|Interleukin-6|T lymphocyte count|CD4+ lymphocyte count|CD8+ lymphocyte count | Myalgia|Diarrhoea | Favipiravir|Lopinavir/Ritonavir | CT scan | Adverse reactions like Diarrhoea|Vomiting|Nausea|Rash|Liver and Kidney injury|Others | Structured |
| NaN | NaN | NaN | Italy | ITA | Interventional | 63 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | Polymerase chain reaction confirmed|Pulmonary involvment, assessed either by oxygen saturation (SaO2) of less than 93% if they were breathing ambient air, or a ratio of partial pressure of oxygen (PaO2) to the fraction of inspired oxygen ( FiO2) of less than 300 mmHg|Markedly deranged proinflammatory and prothrombotic profile (at least 3 of the following): CRP greater than x 10 normal values, D-Dimer x 10 normal values, Lactate dehydrogenase x 2 the upper limits | Age | NaN | D-Dimer|C-Reactive protein|Ferritin|Lymphocyte count|Interleukin-6 | Hypertension|Diabetes|Heart disease|Chronic obstructive pulmonary disease | Tocilizumab | NaN | NA | NaN |
| https://doi.org/10.1001/jamacardio.2020.1834 | NaN | NaN | USA | USA | Interventional | 90 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | NaN | Age|Sex|BMI | NaN | Serum creatinine|White blood cell count|Absolute lymphocyte count|Maximum temperature on day of treatment initiation|C-Reactive protein|Creatine phosphokinase|D-Dimer|Lactate dehydrogenase|Ferritin | Hypertension|Congestive heart failure|Diabetes|Coronary artery disease|Atrial fibrillation|Chronic obstructive pulmonary disease|Asthma | Hydroxychloroquine|Azithromycin | NaN | NaN | Structured |
| https://doi.org/10.1016/j.autrev.2020.102568 | NaN | NaN | Italy | ITA | Interventional | 100 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | NaN | Age|Gender | NaN | White blood cell count|Neutrophil count|Lymphocyte count|Platelet count|Hemoglobin|C-Reactive protein|Interleukin-6|Ferritin|D-Dimer|Fibrinogen|Aspartate aminotransferase|Alanine aminotransferase|Lactate dehydrogenase|Triglycerides|Cholesterol|Creatine kinase|Troponin level | Arterial hypertension|Diabetes|Cardiovascular disease|Chronic kidney disease|Chronic obstructive pulmonary disease|Malignancy|Obesity | Lopinavir/Ritonavir|Remdesivir|Azithromycin|Ceftriaxone|Piperacillin/tazobactum|Hydroxychloroquine|Dexamethasone | NaN | NaN | Structured |
| https://doi.org/10.1016/j.medmal.2020.05.001 | NaN | NaN | France | FRA | Interventional | 20 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging | NaN | NaN | Age|Sex|BMI | quick-Sequential Organ Failure Assessment|Blood Pressure|Confusion or Glasglow scale|Respiratory rate|Oxygen Saturation | Lymphocyte count|C-Reactive protein | Hypertension|Diabetes|Chronic obstructive pulmonary disease|Immunosuppression|Malignancy | Tocilizumab | CT scan | Death|ICU admission|Discharge | Structured |
| https://doi.org/10.3390/microorganisms8050695 | NaN | NaN | Italy | ITA | Interventional | 112 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | NaN | Sex|Age | NaN | Lactate dehydrogenase|Lymphocyte count|Neutrophil count|Alanine aminotransferase|C-Reactive protein|Procalcitonin|Prolactonin|PaO2/FiO2 | Past tumor|Hypertension|Heart disease|Diabetes|Obesity|Lung disease|Other comorbidities | Tocilizumab | NaN | NaN | Structured |
| https://doi.org/10.1016/j.phrs.2020.104899 | NaN | NaN | Italy | ITA | Interventional | 50 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs | NaN | Male or non pregnant fenale aged greater than 18|SARS CoV-2 infection confirmed by postive RT PCR test|Had mechanical ventilation or oxygen saturation (SaO2)level of less than 94% in room air|National Early Warning Score (NEWS)2 greater than equal to 4 | Age|Sex | Temperature | FiO2|PaO2/FiO2|National Early Warning Score 2 (NEWS2)|White blood cell count|Lymphocyte count|Platelet count|Prothrombin time|D-Dimer|Alanine aminotransferase|Lactate dehydrogenase|C-Reactive protein|Serum creatinine | Diabetes|Hypertension|Cancer|Obesity | Remdesivir | NaN | Hospitalization|Death|Disharge | Structured |
| https://doi.org/10.1101/2020.05.02.20080036 | NaN | NaN | USA | USA | Interventional | 900 | African American|White|Asian|Other|Multiracial|Unknown | Demographic|Clinical|Laboratory|Comorbidities | NaN | NaN | Age|Sex|BMI | Respiratory rate|Oxygen Saturation|Pulse|Systolic blood pressure|Diastolic blood pressure|Temperature | White blood cell count|Absolute neutrophil count|Absolute lymphocyte count|Ferritin|D-Dimer|Troponin level|Creatine Phosphokinase|Procalcitonin|Creatinine|C-Reactive protein| | Hypertension|Hyperlipidemia|Coronary artery disease|Heart failure|Asthma|Diabetes|Malignancy|Transplantion|Chronic kidney disease | NaN | NaN | NaN | Structured |
| https://doi.org/10.1016/j.ejim.2020.05.011 | NaN | NaN | Italy | ITA | Interventional | 51 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging | NaN | Age greater than 18 years|Respiratory rate greater than equal to 30 per minutes|SpO2 less than 93% while breathing room air|PaO2/FiO2 less than 250 mmHg|Interleukin-6 plasma level greater than 40pg/mL | Age|Sex | Temperature|Charlson Comorbidity index | White blood cell count|Lymphocyte count|Neutrophil count|Lactate dehydrogenase|Aspartate aminotransferase|Alanine aminotransferase|C-Reactive protein|D-Dimer|Interleukin-6 | Cardiovascular disease|Hypertension|Diabetes|Chronic Lung disease|Cancer|Rheumatalogic disease|HIV|Chronic heapatitis C|Previous tuberculosis | Hydroxychloroquine|Lopinavir/Ritonavir|Remdesivir|Antibiotics|Tocilizumab | CT scan | Hospitalization|Death | Structured |
| https://doi.org/10.1016/j.ejim.2020.05.021 | NaN | NCT04318366 | Italy | ITA | Interventional | 65 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging | NaN | Diagnosis of COVID-19 confirmed upon reverse-transcriptase Polymerase Chain Reaction (RT-PCR) positivity for SARS-CoV-2 on nasopharyngeal swab|Hyper-inflammation defined as elevation in either C-Reactive protein (CRP, greater than equal to 100 mg/L, normal values less than 6 mg/L) or ferritin (greater than equal to 900 ng/mL, normal value less than 400 ng/mL), in the presence of increased lactate de-hydrogenase (LDH, greater than 220 U/L)|Severe respiratory involvement defined by typical radiological findings at chest X-ray and/or computed tomography (CT) scan, in the presence of an oxygen saturation (SaO2) less than equal to 92% while breathing ambient air or a ratio of the partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2) (PaO2:FiO2) less than equal to 300 mmHg | Age|Sex | Temperature | PaO2/FiO2|C-Reactive protein|Lactate dehydrogenase|Non invasive ventilation (NIV) | Arterial hypertension|Chronic obstructive pulmonary disease|Cancer|Coronary artery disease|Type-2 diabetes|Chronic kidney disease | Tocilizumab | CT scan | Hospitilization|Death|Discharge | Structured |
| https://doi.org/10.1101/2020.08.23.20179838 | NaN | NaN | USA | USA|JPN | Observational | 354 | NaN | Demographic|Laboratory|Comorbidities | NaN | NaN | Age|Sex|BMI | NaN | Alanine aminotransferase|Activated partial thromboplastin time|Aspartate aminotransferase|Absolute lymphocyte count|Absolute neutrophil count|Absolute reticulocyte count|Albumin|Blood urea nitrogen|Total bilirubin|C-Reactive protein|Creatinine|D-Dimer|Erythrocyte sedimentation rate|Ferritin|Glucose|Hemoglobin|Interleukin-1 beta|Interleukin-10|Interleukin-6|Lactate dehydrogenase|PT|Platelet count|Procalcitonin|Troponin level|White blood cell count|ANC-ALC-ratio | Lymphoma cancer|Lung cancer|Leukemia cancer|Hypertension|Cardiac arrest|Chronic lower respiratory disease | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.10.15.20209817 | NaN | ISRCTN83971151 | NaN | NaN | Longitudinal | 11266 | NaN | Laboratory|Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| https://doi.org/10.1101/2020.10.15.20209817 | NaN | NCT04315948 | France | FRA | Longitudinal | 3100 | NaN | Laboratory|Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| https://doi.org/10.1001/jama.2020.4326 | NaN | NaN | USA | USA | Observational | 21 | NaN | Clinical|Laboratory|Comorbidities|Imaging | NaN | NaN | NaN | Temperature | White blood cell count|Absolute lymphocyte count|Hemoglobin|Platelet count|Sodium|Creatinine|Total bilirubin|Alkaline phosphatase|Alanine aminotransferase|Aspartate aminotransferase|Creatinine kinase|Venous lactate|Troponin level|Brain-type natriuretic peptide|Procalcitonin | Asthma|Chronic obstructive pulmonary disease|Congestive heart failure|Diabetes|Rheumatalogic disease|Obstructive sleep apnea|Chronic kidney disease|End stage renal failure|History of solid organ transplantion|Cirrhosis|Immunosuppression | NaN | CT scan | Death|Remains critically ill and requires mechanicalventilation|Survived to transfer out of ICU|Length of follow-up for those who survived or remaincritically ill | NaN |
| https://doi.org/10.1101/2020.03.09.20032896 | NaN | NaN | USA | USA | Longitudinal | 12 | NaN | Demographic|Laboratory|Comorbidities|Drugs|Imaging | NaN | NaN | Age|Sex | NaN | SpO2|Aspartate aminotransferase|Alanine aminotransferase|White blood cell count|Procalcitonin | Cardiac arrest|Hypertension|Diabetes|Chronic Lung disease|High cholesterol|Fatty liver disease|Hepatitis B | Remdesivir | CT scan | Critical Care | Unstructured |
| https://doi.org/10.1016/j.tmaid.2020.101663 | NaN | NaN | France | FRA | Observational | 80 | NaN | Demographic|Clinical|Comorbidities|Drugs|Imaging | NaN | NaN | Age|Sex | Temperature | NaN | Cancer|Diabetes|Coronary artery disease|Hypertension|Chronic respiratory diseases|Obesity|Immunosuppressive treatment | Hydroxychloroquine|Azithromycin|Ceftriaxone | CT scan | Death|Discharged|Hospitalization | NaN |
| https://doi.org/10.1056/NEJMoa2004500 | NaN | NaN | USA | USA | Observational | 24 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs|Imaging | NaN | NaN | Age|Sex|BMI | Temperature|Heart Rate|Respiratory rate | White blood cell count|Lymphocyte count|Aspartate aminotransferase|Alanine aminotransferase|Lactate|Serum creatinine|Troponin level|Platelet count|Bilirubin|Creatine kinase | Asthma|Cancer|Chronic analysis|Chronic kidney disease|Chronic obstructive pulmonary disease|Diabetes|Hemorrhagic or ischemic stroke|Human immunodeficiency virus|Obstructive sleep apnea | Hydroxychloroquine|Lopinavir/Ritonavir | CT scan | Death|Discharged|Hospitalization | NaN |
| https://doi.org/10.1101/2020.04.01.20047381 | NaN | NaN | Germany | DEU | Observational | 40 | NaN | Demographic|Clinical|Laboratory|Comorbidities | NaN | NaN | Age | Respiratory rate|Pulse | Lymphoctye count|C-Reactive protein|Bilirubin|White blood cell count|Lactate dehydrogenase|Procalcitonin|Interleukin-6|Thrombocyte count|Troponin level|Creatinine|D-Dimer|Ferritin | Hypertension|Diabetes|Coronary artery disease|Chronic obstructive Lung disease | NaN | NaN | Critical Care | NaN |
| https://doi.org/10.1016/j.medmal.2020.03.006 | NaN | NaN | France | FRA | Observational | 11 | NaN | Clincal|Comorbidities|Drugs|Viral load | NaN | NaN | Age | NaN | NaN | Obesity|Solid cancer|Hematalogical cancer|HIV | Hydroxychloroquine|Azithromycin | NaN | Death|Critical Care | NaN |
| https://doi.org/10.1056/NEJMoa2001191 | NaN | NaN | USA | USA | Observational | 1 | NaN | Demographic|Clinical|Laboratory|Drugs|Imaging|Epidemiological | NaN | NaN | Age|Sex | Temperature|Blood Pressure|Pulse|Oxygen Saturation | White blood cell count|Red blood cell count|Absolute neutrophil count|Absolute lymphocyte count|Platelet count|Hemoglobin|Hematocrit|Sodium|Potassium|Chloride|Calcium|Carbon dioxide|Anion gap|Glucose|Blood urea nitrogen|Creatinine|Total protein|Albumin|Total bilirubin|Procalcitonin|Alanine aminotransferase|Aspartate aminotransferase|Alkaline phosphatase|Fibrinogen|Lactate dehydrogenase|Prothrombin time||Creatine kinase|Venous lactate | NaN | Remdesivir|Vancomycin|Cefepime | CT scan | NaN | Unstructured |
| https://doi.org/10.1542/peds.2020-0702 | NaN | NaN | China | CHN | Observational | 2143 | NaN | Demographic|Laboratory|Comorbidities|Imaging|Epidemiological|Severity of illness | NaN | NaN | Age|Gender | NaN | White blood cell count|Lymphocyte count|C-Reactive protein | Fever|Respiratory symptoms|Digestive symptoms (e.g., vomiting, nausea and diarrhea)|Fatigue | NaN | X ray | NaN | NaN |
| https://doi.org/10.1101/2020.04.26.20073411 | NaN | NaN | USA | USA | Observational | 3055 | Non-Hispanic|Latino|Hispanic|Latino|Unknown | Demographic|Clinical|Laboratory | NaN | NaN | Age|Sex | NaN | NaN | Hypertension|Atrial fibrillation|Coronary artery disease|Heart failure|Stroke|Chronic kidney disease|Diabetes|Asthma|Chronic obstructive pulmonary disease|Cancer | NaN | NaN | Mortality | Unstructured |
| https://doi.org/10.1001/jama.2020.17022 | NaN | NCT02735707 | Australia|Canada|France|Ireland|the Netherlands|New Zealand|the United Kingdom|and the United States. | GBR,USA | Longitudinal | 614 | White|Asian|Black|Mixed|Other | Demographic|Clinical | NaN | NaN | Age|Sex|BMI | NaN | NaN | NaN | NaN | NaN | NaN | Unstructured |
| https://doi.org/10.1101/2020.06.17.20133579 | NaN | EudraCT number: 2020-001934-37 | Spain | ESP | Longitudinal | 85 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | Symptom duration of atleast 7 days|Radiological evidence of Lung disease in chest X-ray or CT scan|ModeRate to severe disease with abnormal gas exchange: PaFi ( PaO2/FiO2) less than 300 or SAFI (SAO2/FiO2) less than 400 or atleast 2 criteria of the RESCIA-COVID Respiratory Severity Scale (BCRSS)|Laboratory parameters suggesting a hyper-inflammatory state: serum C-Reactive Protein (CRP) greater than 15 mg/dl, D-Dimer greater than 800 mg/dl, ferritin greater than 1000 mg/dl or Interleukin-6 levels greater than 20 pg/ml. | Age|Sex | NaN | SAFI(SaO2/FiO2)|Creatinine|Lymphocyte count|Platelet count|C-Reactive protein|D-Dimer|Ferritin | Hypertension|Cardiac arrest|Respiratory disease|Diabetes | Azithromycin|Hydroxychloroquine|Lopinavir/Ritonavir|Methylprednisolone| | NaN | ICU admission|Non invasive ventilation|Mortality | NaN |
| https://doi.org/10.1016/j.jsbmb.2020.105751 | NaN | NCT04366908 | Spain | ESP | Longitudinal | 76 | NaN | Demographic|Laboratory|Comorbidities|Drugs | NaN | NaN | Age|Sex | NaN | PaO2/FiO2|C-Reactive protein|Lactate dehydrogenase|D-Dimer|Lymphocyte count|Ferritin|Interleukin-6 | Lung disease|Chronic kidney disease|Diabetes|High blood pressure|Cardiovascular disease|Immunosuppressed & Transplantioned | Calcifediol|Hydroxychloroquine|Azithromycin | NaN | ICU|Death|Discharged | Unstructured |
| https://doi.org/10.1101/2020.07.01.20139857 | NaN | NCT04342182 | Netherlands | NLD | Longitudinal | 86 | NaN | Demographic|Laboratory|Comorbidities|Drugs|Disease severity | NaN | COVID-19 related symptoms for 10 days and had been admitted to the hospital for 2 days|Tested positive for anti-SARS-CoV-2 antibodies|Ig ratio was greater than 10 | Age|Sex | NaN | C-Reactive protein|Ferritin|Lactate dehydrogenase|Lymphocyte count|Bilirubin|WHO COVID-19 disease severity score|PRNT50 titer|Wantai ELISA positive | Diabetes|Hypertension|Cardiac arrest|Pulmonary disease|Cancer|Immunodeficiency|Chronic kidney disease|Liver cirrhosis | Chloroquine|Azithromycin|Lopinavir/Ritonavir|Tocilizumab|Anakinra | NaN | Death|Hospitalizaiton | NaN |
| https://doi.org/10.1001/jama.2020.10044 | NaN | ChiCTR2000029757 | China | CHN | Longitudinal | 103 | NaN | Demographic|Clinical|Laboratory|Viral load|Comorbidities | NaN | Signed informed consent|Aged at least 18 years|COVID-19 diagnosisbased on polymerase chain reaction (PCR) testing|Posi-tive PCR result within 72 hours prior to randomization|Pneumonia confirmed by chest imaging|Clinical symp-toms meeting the definitions of severe or life-threatening COVID-19|Acceptance of random group assignment|Hospital admission|Willingness to participate in allnecessary research studies and be able to complete the study follow-up|No participation in other clinical trials,such as antiviral trials, during the study period | Age|Sex | Temperature|Respiratory rate|Heart Rate|Systolic blood pressure | White blood cell count|Neutrophil count|Platelet count|C-Reactive protein|Interleukin-6|Prothrombin time|Activated partial thromboplastin time|Thrombin time|Fibrinogen|D-Dimer|Alanine aminotransferase|Aspartate aminotransferase|Urea nitrogen|Serum creatinine | Hypertension|Cardiovascular disease|Cerebrovascular disease|Diabetes|Liver disease|Cancer|Kidney disease | NaN | NaN | Mortality | Structured |
| https://doi.org/10.1101/2020.04.03.20052001 | NaN | NCT04426344 | USA | USA | Longitudinal | 20 | NaN | Demographic|Clinical|Laboratory | NaN | Patients above the age of 18 years old|Patients with a diagnosis of COVID-19 on mechanical ventilation|Patient maximum baseline temperature (within previous 12 hours) less than 38.3°C|Patients must have a surrogate or legally authorized representative able to understand and critically review the informed consent form | Age|Sex|Height|Weight | Temperature|Blood Pressure|Heart Rate|Respiration Rate | Complete blood count (CBC)|Chemistry profiles|Liver function tests|C-Reactive protein|Ferritin|D-Dimer|Arterial blood gas for determination of PaO2 | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.04.07.20056762 | www.unmc.edu/publichealth/departments/biostatistics/jianghu-dong.html | NaN | China | CHN | Observational | 167 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Imaging | NaN | NaN | Age|Sex | Temperature|Pulse|Respiratory rate|Blood Pressure | C-Reactive protein|White blood cell count|Red blood cell count|Lymphocyte count|Hemoglobin|Plasma Prothrombin time determination|Thrombin time|Activated partial thromboplastin time|D-Dimer|Alanine aminotransferase|Urea nitrogen|Fibrinogen|Eosinophil count|Hematocrit | High blood pressure|Diabetes|Cardiogenic diseases|Lung disease|Anaemia|Stroke|Kidney disease|Surgery|Liver disease | NaN | CT scan | NaN | NaN |
| https://doi.org/10.1128/AAC.01897-20 | https://rctportal.niph.go.jp/en/detail?trial_id=jRCTs041190120 | JPRN-jRCTs041190120 | Japan | JPN | Interventional | 86 | NaN | Proportion of subjects with clearance of SARS-CoV2 in nasopharyngeal swab by Day 6 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04423991 | NCT04423991 | USA | USA | Interventional | 290 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04358510 | NCT04358510 | USA | USA|JPN | Observational | 114 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| https://doi.org/10.1002/joa3.12405 | https://clinicaltrials.gov/show/NCT04395664 | NCT04395664 | Denmark | DNK | Observational | 1000 | NaN | In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis|Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis|Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis|Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis|Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| NaN | http://www.drks.de/DRKS00021424 | DRKS00021424 | Germany | DEU | Observational | 360 | NaN | Omics (oropharyngeal mikrobiota) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.mayocpiqo.2020.07.003 | http://www.drks.de/DRKS00021658 | DRKS00021658 | Germany | DEU | Observational | 100 | White|African American|Hispanic|Other | Demographic|Clinical|Laboratory|Comorbidities | NaN | NaN | Age|Sex|BMI | NaN | NaN | Hypertension|Diabetes|Hyperlipidemia|Cardiac arrest|Chronic kidney disease|Chronic obstructive pulmonary disease|Stroke or dementia|Smoking|Malignancy|Obesity | NaN | NaN | NaN | NaN |
| NaN | http://isrctn.com/ISRCTN13311119 | ISRCTN13311119 | India | IND | Interventional | 116 | NaN | Laboratory|Viral load | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://isrctn.com/ISRCTN87832712 | ISRCTN87832712 | Italy | ITA | Observational | > 20 | NaN | Oral microbiome|Cytokine|Viral load | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://isrctn.com/ISRCTN10980107 | ISRCTN10980107 | UK | GBR | Observational | 10000 | NaN | Laboratory|Clinical|Questionnaires|Viral load|Biosampling for omics | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://isrctn.com/ISRCTN14990068 | ISRCTN14990068 | Switzerland | CHE | Observational | 3200 | NaN | Viral load|Hospital stay|Questionnaries | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://www.isrctn.com/ISRCTN44324934 | ISRCTN44324934 | UK | GBR | Longitudinal | 135 | NaN | Viral load|Serum antibody level | NaN | Any patient-facing clinical staff member working regularly in the Children’s Emergency Department (CED) of Bristol Royal Hospital for Children, including doctors, nurses and healthcare assistants | Age|Sex | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://www.isrctn.com/ISRCTN64783542 | ISRCTN64783542 | UK | GBR | Longitudinal | 1000 | NaN | Demographic|Coagulation parameters|Blood clotting capability|Clinical|Laboratory | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://www.isrctn.com/ISRCTN45562523 | ISRCTN45562523 | UK | GBR | Observational | 5782649 | NaN | Viral load|Hospital stay|ICD10 codes for hospital discharge diagnoses|CCU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.ijid.2020.11.149 | https://www.isrctn.com/ISRCTN74727214 | ISRCTN74727214 | Oman | OMN | Retrospective | 75 | NaN | Inflammatory biomarker|IMV | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://www.isrctn.com/ISRCTN13035264 | ISRCTN13035264 | UK | GBR | Interventional | 1063 | Hispanic or Latino|Not Hispanic or Latino|Unknown or Not Reported | Demographic|Laboratory|Drugs|Comorbidities|Serious adverse events (SAEs)|Clinical | Alanine transaminase (ALT) or Aspartate transaminase (AST) greater than 5 times the upper limit of normal|Estimated glomerular filtration rate (eGFR) less than 30 ml/min (including patients receiving hemodialysis or hemofiltration)|Pregnancy or breast feeding|Anticipated discharge from the hospital or transfer to another hospital which is not a study site within 72 hours|Allergy to any study medication | NaN | Age|Sex | NaN | Alanine transaminase|Aspartate transaminase|Creatinine|Glucose|Hemoglobin|Platelet count|Prothrombin time|Total bilirubin|White blood cell count|Neutrophil count|Lymphocyte count|Monocyte count|Basophil count|Eosinophil count | Coagulopathy|Febrile neutropenia|Anaemia|Cardiac arrest|Atrial fibrillation|Cardio-respiratory arrest|Myocardial infarction|Supraventricular tachycardia|Ventricular tachycardia|Acute myocardial infarction|Cardiac failure|Cardiogenic shock|Acute coronary syndrome|Arrhythmia|Palpitations|Pulseless electrical activity|Ventricular fibrillation|Cardiac tamponade | Remdesivir | NaN | Death|Hospitalizaiton | NaN |
| NaN | https://www.isrctn.com/ISRCTN40302986 | ISRCTN40302986 | Nigeria | NGA | Double-blind clinical trial | 45 | NaN | Viral load|Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| NaN | http://www.anzctr.org.au/TrialSearch.aspx | ACTRN12620000554965 | Australia | AUS | Longitudinal | 300 | NaN | Immunology|Lung and gut microbiome | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://www.anzctr.org.au/TrialSearch.aspx | ACTRN12620000421932 | Australia | AUS | Longitudinal | 10000 | NaN | Clinical|ICU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04327804 | NCT04327804 | USA | USA | Longitudinal | 120 | NaN | Viral load | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04330599 | NCT04330599 | UK | GBR | Longitudinal | 12000 | NaN | Diverse clinical and social end points | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1007/s10554-020-02010-4 | https://clinicaltrials.gov/show/NCT04358952 | NCT04358952 | France | FRA | Longitudinal | 50 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Viral load|Electrocardiogram|Inflammatory parameter | NaN | NaN | Age|Sex|BMI | Systolic Arterial pressure|Diastolic Arterial pressure|Heart Rate | High-sensitivity Troponin|NT-proBNP|Creatinine|Leukocyte count|Lymphocyte count|Platelet count|Hemoglobin|C-Reactive protein|Alanine aminotransferase|Aspartate aminotransferase|Estimated glomerular filtration rate | Hypertension|Diabetes|Hypercholesterolemia|Obesity|Cerebrovascular disease|Chronic renal failure|Chronic obstructive pulmonary disease|Sleep disordered breathing | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04368143 | NCT04368143 | Belgium | BEL | Longitudinal | 100 | NaN | B and T cell repertoires | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04378777 | NCT04378777 | USA | USA | Longitudinal | 2000 | NaN | Clinical|ICU|Biosampling | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04385108 | NCT04385108 | France | FRA | Longitudinal | 170 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04393155 | NCT04393155 | USA | USA | Longitudinal | 225 | NaN | Immunology|FVC|FEV1 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1007/s00125-020-05180-x | https://clinicaltrials.gov/show/NCT04324736 | NCT04324736 | France | FRA | Observational | 1317 | Europid|Middle East North Africa|African or Caribbean|Asian | Demographic|Laboratory|Comorbidities | NaN | Hospitalisation in a dedicated COVID-19 unit with COVID-19 diagnosis confirmed biologically (by SARS-CoV-2 PCR test) and/or clinical-ly/radiologically (i.e. as ground-glass opacity and/orcrazy paving on chest computed tomography [CT]scan)|Personal history of diabetes or newly diag-nosed diabetes on admission | Age|Sex|BMI | NaN | Positive SARS-CoV-2 PCR|Admission plasma glucose|Plasma creatinine|Estimated glomerular filtration rate|Alanine aminotransferase|Aspartate aminotransferase|Glutamyl transferase|Hemoglobin|White blood cell count|Lymphocyte count|Platelet count|D-Dimer|C-Reactive protein|Lactate dehydrogenase|Fibrinogen|Creatinine phosphokinase | Heart failure|Liver cirrhosis|Cancer|Chronic obstructive pulmonary disease|Obstructive sleep apnea|Organ failure|End stage renal failure | NaN | CT scan | Death|Discharged | NaN |
| NaN | http://www.drks.de/DRKS00023418 | DRKS00023418 | Germany | DEU | Longitudinal | 3000 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | http://isrctn.com/ISRCTN15634328 | ISRCTN15634328 | UK | GBR | Longitudinal | 2000 | NaN | Antibody titer | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.jphys.2020.03.011 | http://www.ensaiosclinicos.gov.br/rg/RBR-2f9k8p/ | RBR-2f9k8p | Brazil | BRA | Longitudinal | 2000 | NaN | Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ensaiosclinicos.gov.br/rg/RBR-7nky44/ | RBR-7nky44 | Brazil | BRA | Observational | 703 | NaN | Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04337762 | NCT04337762 | USA | USA | Observational | 100000 | NaN | Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1038/s41598-021-84356-w | https://clinicaltrials.gov/show/NCT04411576 | NCT04411576 | Sweden | SWE | Observational | 40000 | NaN | Demographic|Sick leave records|Clinical|Sequencing | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1172/JCI141772 | https://clinicaltrials.gov/show/NCT04355611 | NCT04438629 | Italy | ITA | Observational | 80 | NaN | Immunology|Pao2/FiO2 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.msard.2020.102482 | https://clinicaltrials.gov/show/NCT04355611 | NCT04355611 | France | FRA | Observational | 2000 | NaN | 7-point severity scale at Nadir | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04347694 | NCT04347694 | Austria | AUT | Observational | 400 | NaN | Demographic|Laboratory|Comorbidities|COVID-19 diagnostic | NaN | NaN | Age|Sex|BMI | NaN | IgG|IgA|IgM | Hypertension|Diabetes|Cornoary artery disease|Chronic kidney disease|Lung disease|Autoimmune disease|Cancer | NaN | NaN | NaN | NaN |
| https://doi.org/10.1186/s13054-020-03123-x | NaN | ChiCTR2000029770 | China | CHN | Observational | 828 | NaN | Demographic|Clinical|Imaging|Laboratory|Medical records | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| https://doi.org/10.1101/2020.07.17.20155937 | NaN | NaN | Sweden | SWE | Observational | 105 | NaN | Demographic|Laboratory|COVID-19 diagnostic | NaN | NaN | Age|Sex | NaN | Interleukin-6|PSV ID50|IgG (Spike)|IgG (Receptor binding domain)|IgM (Spike)|IgM (Receptor binding domain)|IgA (Spike)|IgA (Receptor binding domain) | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.06.08.20125245 | NaN | NaN | Spain | ESP | Observational | 1229 | NaN | Demographic|Clinical|Laboratory|Comorbidities|Drugs | NaN | Heightened high CRP levels | Age|Sex | Heart Rate|Systolic blood pressure|Temperature|Oxygen Saturation | Absolute lymphocyte count|Absolute neutrophil count|Lactate dehydrogenase|Alanine aminotransferase|Urea|C-Reactive protein|D-Dimer|Interleukin-6 | Hypertension|Diabetes|Congestive heart failure|Coronary artery disease|Chronic kidney disease|Lung disease | Tocilizumab | NaN | ICU|Mortality | NaN |
| https://doi.org/10.1056/NEJMoa2028836 | https://clinicaltrials.gov/show/NCT04356937 | NCT04356937 | USA | USA | Interventional | 243 | NaN | Clinical|ICU|Ordinal scale scores | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.07.02.20145565 | NaN | NaN | USA | USA | Observational | 205 | Hispanic|Non-Hispanic African American|Non-Hispanic White|Others | Demographic|Laboratory|Comorbidities|Drugs|ICU transfer|Intubation|In-hospital mortality | NaN | Age greater than 18years old|Confirmed cases of SARS-CoV-2 by PCR method|Admitted in general wards|PaO2/FiO2 less than 300 if Arterial blood gas was available or SpO2/Fio2(SF)ratio kess than 440|Bilateral infiltRate on chest imaging validated by radiology staff | Age|Sex|BMI | NaN | PaO2/FiO2|SpO2/FiO2|Sequential Organ Failure Assessment|Hemoglobin|White blood cell count|Absolute lymphocyte count|Platelet count|Globular filtration rate|Aspartate aminotransferase|Alanine aminotransferase|Procalcitonin|Ferritin|Lactate dehydrogenase|D-Dimer|C-Reactive protein|Interleukin-6 | Obesity|Hypertension|Diabetes|Chronic Lung disease|Cancer|Coronary artery disease|Heart failure | Corticosteriod|Hydroxychloroquine|Tocilizumab|Enoxaparin therapeutic dose | NaN | NaN | NaN |
| NaN | NaN | NCT04370262 | USA | USA | Interventional | 942 | NaN | Clinical|7-point ordinal scale | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/S2213-2600(20)30268-X | https://clinicaltrials.gov/show/NCT04365959 | NCT04365959 | Italy | ITA | Observational | 56 | NaN | Demographic|Laboratory|Comorbidities|Anthropometrics|Arterial blood gas|Ventilation parameters|Oxygenation | NaN | NaN | Age|Sex|BMI | NaN | Sodium|Potassium|Chlorine|Creatinine|Urea|White blood cell count|Platelet count|Hemoglobin|Hematocrit|Bilirubin|C-Reactive protein|Procalcitonin|Lactate dehydrogenase|Aspartate aminotransferase|Alanine aminotransferase|Activated partial thromboplastin time|D-Dimer|pH|PaO2|PaCO2|SaO2 | Previous myocardial infarction|Congestive heart failure|Hypertension|Vascular disease|Chronic bronchopulmonary disease|Gastric or liver disease|Diabetes|Chronic kidney disease|Solid malignancy | NaN | NaN | Death|Hospitalizaiton | NaN |
| https://doi.org/10.1007/s10875-020-00839-x | https://clinicaltrials.gov/show/NCT04365959 | NCT04262921 | France | FRA | Observational | 5000 | NaN | Clinical|Biological|Radiological and virological assessments|Immunology | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1038/s41467-020-17240-2 | NaN | NaN | China | CHN | Observational | 41 | NaN | Demographic|Clinical|Laboratory|Comorbidities | NaN | NaN | Age|Sex | Temperature | Leukocyte count|Neutrophil count|Lymphocyte count|Platelet count|Hemoglobin|Activated partial thromboplastin time|Prothrombin time|Prothrombin time|D-Dimer|Albumin|Alanine aminotransferase|Aspartate aminotransferase|Total bilirubin|Serum creatinine|Lactate dehydrogenase|Interleukin-6|C-Reactive protein|Procalcitonin|Erythrocyte sedimentation rate|Serum ferritin | Hypertension|Diabetes|Malignancy|Chronic liver disease | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.cmet.2020.06.015 | https://clinicaltrials.gov/show/NCT04330586 | NCT04330586 | Korea | KOR | Interventional | 94 | NaN | Clinical|Viral load|ICU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.cmet.2020.06.015 | NaN | NaN | China | CHN | Observational | 13981 | NaN | Demographics|Clinical|ICU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04407273 | NCT04407273 | Spain | ESP | Observational | 1200 | NaN | WHO SARS-CoV-2 scale of severity (9 steps) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.cels.2020.10.003 | https://covid-omics.app | NaN | USA | USA | Observational | 128 | White|Black|Asian|Hispanic|Other | Demographic|Clinical|Laboratory|RNA-seq|Drugs|High-resolution mass spectrometry|WHO ordinal score at 28 days|HFD-45 | NaN | NaN | Age|Sex|BMI | NaN | Ferritin|C-Reactive protein|D-Dimer|Procalcitonin|Lactate|Fibrinogen|Albumin|White blood cell count|Hemoglobin|Corpuscular volume|Platelet count|Neutrophil count|Lymphocyte count|Monocyte count|Eosinophil count|PaO2/FiO2|Positive-end expiratory pressure|Inspiratory plateau | NaN | Hydroxychloroquine|Replacement therapy (pre-enrollment)|Antibiotics|Antiviral|IL6 - antagoinist|Convalescent plasma|Steroids|Therapeutic anticoagulation | NaN | NaN | NaN |
| https://doi.org/10.1016/j.eclinm.2020.100449 | https://www.risc-19-icu.net | NCT04357275 | Switzerland | CHE | Observational | 10000 | NaN | ICU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1148/radiol.2020202422 | https://clinicaltrials.gov/show/NCT04362930 | NCT04362930 | France | FRA | Observational | 2000 | NaN | Demographic|ICU|Brain MRI| | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.06.11.20128041 | https://www.risc-19-icu.net | NCT04357275 (partly) | Switzerland | CHE | Observational | 28 | NaN | Demographic|Comorbidities|ICU|Laboratory | NaN | NaN | Age|Sex|BMI | NaN | NaN | Coronary artery disease|Chronic Heart failure|Peripheral artery disease|Arterial hypertension|Diabetes | NaN | NaN | NaN | NaN |
| https://doi.org/10.1186/s13054-020-03286-7 | https://clinicaltrials.gov/show/NCT04350073 | NCT04350073 | USA | USA | Observational | 120 | NaN | ICU|Laboratory|Metabolic parameter (e.g.|pREE) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04401033 | NCT04401033 | Spain | ESP | Observational | 450 | NaN | Clinical|Laboratory | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1001/jamaoto.2020.5074 | https://clinicaltrials.gov/show/NCT04407494 | NCT04407494 | France | FRA | Observational | 809 | NaN | Diagnostic values of anosmia and ageusia for COVID-19|Diagnostic values of CODA (Clinical Olfactory dysfunction Assessment) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04358536 | NCT04358536 | USA | USA | Observational | 230 | NaN | Clinical | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.rmed.2021.106312 | https://clinicaltrials.gov/show/NCT04407260 | NCT04407260 | USA | USA | Observational | 136 | NaN | Oxygen Saturation||Intubation/mechanical Ventilation | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04480060 | NCT04480060 | Turkey | TUR | Observational | 100000 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| https://doi.org/10.1007/s11239-020-02235-z | https://clinicaltrials.gov/show/NCT04374617 | NCT04374617 | Spain | ESP | Observational | 230 | NaN | NA | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Venous thromboembolisms|Mortality | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04466644 | NCT04466644 | USA | USA | Observational | 340 | NaN | Prevalence of contagiousness in asymptomatic individuals by PCR with nasopharyngeal swabs|Ratio of asymptomatic immunized (IgG) population | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/show/NCT04409249 | NCT04409249 | Turkey | TUR | Observational | 155 | NaN | Factors affecting prognosis | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1111/aas.13694 | https://clinicaltrials.gov/show/NCT04337502 | NCT04337502 | Netherlands | NLD | Observational | 300 | NaN | Predictive performance | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04479137 | NCT04479137 | Turkey | TUR | Observational | 5000 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04445961 | NCT04445961 | Russia | RUS | Observational | 117 | Optimum positive end-expiratory pressure | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | |
| https://doi.org/10.1016/j.amsu.2020.11.006 | https://clinicaltrials.gov/ct2/show/NCT04480580 | NCT04480580 | Italy | ITA | Observational | 100 | NaN | Demographic|Imaging|Seroprevalence of SARS-CoV-2 | NaN | NaN | Age|Sex | NaN | NaN | NaN | NaN | CT scan | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04374123 | NCT04374123 | Ecuador | ECU | Observational | 111 | NaN | COVID-19 infection in the staff documented via PCR|serum levels of IgG and IgM against COVID-19|Endoscopic records of patients treated during the COVID-19 protocol | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04387799 | NCT04387799 | Italy | ITA | Observational | 520 | NaN | Serology|Efficacy of CT scan and Serology|Efficacy of different pharmaceutical treatments against Covid-19 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04577105 | NCT04577105 | Mexico | MEX | Observational | 233 | NaN | Level of suspicion of SARS-CoV2 infection | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://clinicaltrials.gov/ct2/show/NCT04357535 | NCT04357535 | Saudi arabia | SAU | Observational | 314 | NaN | Severity of COVID-19 Infection|PaO2/FiO2 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04412304 | NCT04412304 | Sweden | SWE | Observational | 166 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Hyponatremia|Mortality|Hyponatremia|ICU | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04453501 | NCT04453501 | France | FRA | Observational | 132 | NaN | Risk factor measurements | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04554979 | NCT04554979 | Egypt | EGY | Observational | 199 | NaN | GIT manifestations|Disease spectrum and duration | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1093/cid/ciaa601 | https://ClinicalTrials.gov/show/NCT04374071 | NCT04374071 | USA | USA | Observational | 250 | NaN | Transfer to Intensive care unit (ICU)|Need for Mechanical Ventilation||Development and Severity of ARDS|Length of hospital stay (LOS) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04393428 | NCT04393428 | France | FRA | Observational | 100 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.08.06.20169599 | https://ClinicalTrials.gov/show/NCT04462393 | NCT04462393 | Sweden | SWE | Observational | 1563 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality|ICU | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04518735 | NCT04518735 | Spain | ESP | Observational | 1707 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality|Transfer to the Intensive Care Unit (ICU)|Thromboembolic complications|Major bleeding complications | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04433754 | NCT04433754 | Turkey | TUR | Observational | 500 | NaN | NaN | NaN | NaN | NaN | NaN | C-Reactive protein|D-Dimer | Fever|Dyspnea | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04452682 | NCT04452682 | Egypt | EGY | Observational | 998 | NaN | ICU | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04390074 | NCT04390074 | Sweden | SWE | Observational | 9905 | NaN | Chronic medications as risk factor of intensive care for COVID-19|Comorbidities as risk factor of intensive care for COVID-19|Chronic medications as risk factor of death during intensive care for COVID-19|Comorbidities as risk factor of death during intensive care for COVID-19 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1101/2020.08.26.20180992 | https://ClinicalTrials.gov/show/NCT04488588 | NCT04488588 | Egypt | EGY | Observational | 1964 | NaN | Number of co-morbidities in hospitalized patients with COVID-19|Causes of ICU admission | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04341766 | NCT04341766 | France | FRA | Observational | 106 | NaN | Characteristics of pulmonary ultrasound for Covid-19 patients|ChaRateristics of pulmonary CT-scan for Covid-19 patients | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04527458 | NCT04527458 | UK | GBR | Observational | 70000 | NaN | Case fatality | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1111/aas.13694 | https://ClinicalTrials.gov/show/NCT04378582 | NCT04378582 | Brazil | BRA | Observational | 1589 | NaN | ICU survival at 28 days|Hospital survival at 60 days|Duration of mechanical ventilation|Need for renal replacement therapy|Complications during the ICU stay | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1371/journal.pone.0244853 | https://ClinicalTrials.gov/show/NCT04485169 | NCT04485169 | Pakistan | PAK | Interventional | 280 | NaN | Survival|Duration of hospitalization|Timing of PCR negativity|Time to CRS resolution|Complications | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1714/3343.33127 | https://ClinicalTrials.gov/show/NCT04318418 | NCT04318418 | Italy | ITA | Observational | 3400 | NaN | Severe COVID-19|Death | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04365634 | NCT04365634 | China | CHN | Observational | 306 | NaN | Demographic|Clinical|Laboratory|Imaging|Drugs|Comorbidities | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1536/ihj.20-323 | https://ClinicalTrials.gov/show/NCT04318301 | NCT04318301 | China | CHN | Observational | 275 | NaN | Rate of Death|Severity of pneumonia | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04355871 | NCT04355871 | Spain | ESP | Observational | 4035 | NaN | Mechanical ventilation | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| https://doi.org/10.1016/j.thromres.2020.11.001 | https://ClinicalTrials.gov/show/NCT04420312 | NCT04420312 | France | FRA | Observational | 1024 | NaN | Clinical|Imaging | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04493268 | NCT04493268 | Argentina | ARG | Observational | 250 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality|ICU | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04292964 | NCT04292964 | China | CHN | Observational | 201 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | Mortality|Severe state | NaN |
| https://doi.org/10.1093/cid/ciaa601 | https://ClinicalTrials.gov/show/NCT04344327 | NCT04344327 | France | FRA | Observational | 2878 | NaN | Death Rate|ICU|Ventilation analysis | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| NaN | https://ClinicalTrials.gov/show/NCT04425213 | NCT04425213 | France | FRA | Observational | 250 | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | ICU|Mortality|Invasive mechanical ventilation | NaN |
Geographic location of the studies
Serology Studies
Metadata of the studies included in the viewer.
| Publication reference | URL of Dataset | Clinical Trial ID | Country | Country code | Study design | Total number of subjects | Ethnicity | Existent variables | Exclusion criteria | Inclusion criteria | Demographic | Clinical variables | Laboratory variables | Comorbidities | Drugs | Imaging | Endpoint | Type of data |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PMID:33173900 | https://www.medrxiv.org/content/10.1101/2020.11.05.20226654v1.supplementary-material | NaN | USA | USA | Longitudinal | 29.0 | Black|Latino|White|Other | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Ethnicity | Serum samples | IgA|IgG|IgM | Diabetes|Obesity|Hypertension|Cardiovascular disease|Renal Disease|Chronic Lung Disease|Stroke | NaN | Fluorescent detector—the D4Scope | log(D4 intensity a.u.) | NaN |
| PMID:33531472 | https://github.com/linsemanlab/Grossberg-Koza-et-al-2021 | NaN | USA | USA | Longitudinal | 107.0 | White|Asian|Hispanic|Latino|Spanish | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|BMI|Ethnicity | Questionnaire | IgA|IgG|IgM | Smoking history|Cardiovascular disease|Diabetes|Autoimmune disease|Tick-Borne illness|Hemochromatosis|Blood related disease | NaN | Chemuluminescent immunoassay | IgA|IgG|and IgM antibody titers | Structured |
| PMID:32994364 | https://science.sciencemag.org/content/suppl/2020/09/28/science.abd4250.DC1 | NaN | USA | USA | Longitudinal | 420.0 | Asian|Black|Black_Hispanic|Hispanic|Other|Unknown|White|White_Hispanic | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Ethnicity | Cohort 1: plasma samples|date of initial symptom onset|symptom type|date of diagnosis|date of symptom cessation|and severity of symptoms/ Cohort 2: Serum samples symptom duration and comorbidities/ Cohort 3: plasma samples|days since symptom onset| results of COVID-19 molecular testing/ Cohort 4: blood sample|demographic|past medical|and clinical data/ Cohort 5 and 6: Remnant serum specimens|onset of symptom/ Cohort 7 and 8: serum samples/ Cohort 9: plasma samples | IgG|IgA | NaN | NaN | NaN | IgG|IgA antibody titers | Structured |
| PMID:32337590 | https://academic.oup.com/cid/article/71/16/2255/5825506#supplementary-data | NaN | China | CHN | Longitudinal | 41.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Epidemiological history | Serum samples | IgG |IgM|Serological responses to SARS-CoV-2| Detection of nucleocapsid (N) protein and spike (S) glycoprotein | NaN | NaN | Chemuluminescent immunoassay | IgG|IgM | Structured |
| PMID:32948854 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498988/, https://data.mendeley.com/datasets/2f73pzdkr4/1 | NaN | USA | USA | Longitudinal | 445.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples | IgA|IgG|IgM | Diabetes|Immunosuppression|Lung Disease|Heart Disease | NaN | Multicolour imaging | IgA|IgG|IgM | Structured |
| PMID:32817357 | https://stm.sciencemag.org/content/suppl/2020/08/17/scitranslmed.abc3103.DC1 | NCT04325646 | France | FRA | Longitudinal | 751.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Questionnaire|Sociodemographic information|Underlying medical conditions|History of respiratory symptoms back to 13 January 2020|History of COVID-19 diagnosis before this investigation | IgA|IgG|IgM | NaN | NaN | NaN | Seroprevalence|optical density|IgG| IgM |IgA reactivity against purified tri-S proteins | Structured |
| PMID:32783920 | ttps://doi.org/10.1016/j.immuni.2020.07.020 | NaN | USA | USA | Longitudinal | 66.0 | Asian|Black|White | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Ethnicity|Intervention | Plasma samples | IgA|IgG|IgM | NaN | Chloroquines|Remdesivir|Tocilizumab|Antibiotics | NaN | IgA|IgG|IgM Antibody responses | Structured |
| PMID:32897389 | https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/clinchem/66/12/10.1093_clinchem_hvaa213/1/hvaa213_supplementary_data.docx?Expires=1621248273&Signature=1f7Y0LlTdMNp-fSuW89LWJYjgx5BD4C4m3k839gAop3uSBnQgks8mXdXUlbZG~S6DDBLpHDhu52qBSfryqSZSkPR4XUPxRc~FM-mlLcRqGQ9ljNwNLFBFwTMJQPIfIaDtzENNP5tJShl~KNx6Amw2eQW4N2VEy~V4dimRThAja1Cmrt0cyMO3tNiqr-1qgFf8oenyeM6BLoVhLOwpn6boi4r0jk9Hze7uyHq~obUiJ0TYjw2ANhcqOkC4OQdw0sW~3rKVf0vaPbjjDZYka3tvuigpMi2a22T-D022iH0-LDVdHWiwow8z8wjSo86aFHXHprijVmmVTgSDYDcGfpwpg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA | NaN | USA | USA | Longitudinal | 64.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Plasma samples|Patient disposition at time of admission. Was Patient Immunosuppressed?|Fraction of patients admitted to ICU|Fraction of patients intubated| Days between hospitalization and intubation|Length of intubation | SARS-CoV-2 S1 and N antigen detection|Serological responses | NaN | NaN | NaN | IgG|IgM|and IgA each against S1|Spike|N|and receptor binding domain (RBD) | Structured |
| PMID:33040337 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675426/ | NaN | China | CHN | Longitudinal | 1056.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Healthy|Asymptomatic|Mild symptoms | Serum IgM and IgG antibodies|Serum proteome microarray | NaN | NaN | NaN | IgM|IgG responses | Structured |
| PMID:32705575 | NaN | NaN | China | CHN | Longitudinal | 88.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples| Mild/moderate symptoms|Severe(critical symptoms) | IgG|IgM|Antibody titer | NaN | NaN | Chemiluminescence immunoassay | IgG|IgM | Structured |
| PMID:33397903 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217240/bin/NIHPP2020.04.15.043364-supplement-1.pdf | NaN | USA|Switzerland | USA|CHE | Comparative | 22.0 | NaN | Clinical|Laboratory | NaN | NaN | NaN | Plasma samples | IgG|IgA | NaN | NaN | Human IgG and IgA secondary antibodies conjugated to quantum dot fluorophores Q800 and Q585 | IgG|IgA | Structured |
| PMID:32913364 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482996/# | NaN | China | CHN | Longitudinal | 26.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Throat swab samples|Serum samples|Onset signs and symptoms|Duration of positive viral RNA|ct value of RT-PCR|Lymphocyte|CRP|ESR|IL-6 | IgG|IgM | Diabetes|Hypertension|Alzheimer's Disease|Cerebral infarction|Liver cyst | hormone|interferon atomization|Lopinavir/Ritonavir|Immunoglobulin|Arbidol|Darunavir|Thymosin|Ribavirin | NaN | IgG|IgM | Structured |
| PMID:32389784 | https://www.journalofinfection.com/article/S0163-4453(20)30244-9/fulltext | NaN | France | FRA | Longitudinal | 22.0 | NaN | Clinical|Laboratory | NaN | NaN | NaN | Serum samples | IgM|IgG|Antibody detection | NaN | NaN | NaN | IgM|IgG | Structured |
| PMID:33019628 | https://www.mdpi.com/2077-0383/9/10/3188/s1 | NaN | Italy | ITA | Longitudinal | 546.0 | NaN | Clinical|Demographic|Laboratory | Inability to provide informed consent | Health care workers (medical doctors, practitioners, post-graduate students, nurses), potentially exposed to SARS-CoV-2 between February and June 2020|Documented SARS-CoV-2 infection by NF swab|Not being hospitalized for COVID-19; For those hospitalized with COVID-19: Documented SARS-CoV-2 infection by NF swab| Being admitted in the ICU between February and June 2020 for COVID-19; For negative controls: sera being collected before 2019 | Age|Sex | Serum samples|Disease duration|Symptoms | IgM|IgG |IgA | Obesity|Cardiopulmonary|Diabetes|Renal|Vasculopathy|Multile comorbidities | NaN | NaN | IgM|IgG|IgA|Cytokines|Chemokines | Structured |
| PMID:33177504 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658256/# | NaN | Australia | AUS | Longitudinal | 5.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serial samples including blood,saliva, NP, swabs, feces and urine|Symptoms recording | Anti-S1 salivary IgA|IgG|IgM|Immune profiling | NaN | NA | NaN | IgA|IgG|IgM|IL-1α|IL-1β|IL-6|IFNα|TNFα|MIP-1α|MCP-1|IL-8|RANTES|IL-12p70|IL-10|IL-2|IL-5|IL-5|IL-9|IL-13|IFNγ|IL-17A|20,000 randomly selected live single cells per patient per time point | Structured |
| PMID:32511499 | https://www.medrxiv.org/content/early/2020/05/14/2020.05.10.20097535.external-links | NaN | USA | USA | Cross-sectional | 180.0 | Asian|Afro American|Non-hispanic Caucasian|Hispanic|Other | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Ethnicity | Serum samples|Plasma samples|Days since symptom onset|Respiratory failure requiring intubation|Duration of disease|Clinical symptoms | IgM|IgG | NaN | NaN | NaN | IgG|IgM | Structured |
| PMID:33133098 | NaN | NaN | Italy | ITA | Longitudinal | 2.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Nasopharyngeal swabs|Oxygen saturation on room air|HIGH Resolution CT (HRCT)|Hospitalization weeks|CPAP | IgM|IgG|IgA|White cell count|Absolute lymphocyte count|C-reactive protein|Ferritin|Il-6|D-dimer | arterial hypertension|trans-catheter ablation of atrial fibrillation|and right hemisphere ischemic stroke. | NaN | NaN | IgM|IgG|IgA | Structured |
| PMID:32711254 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375792/# | NaN | Singapore | SGP | Longitudinal | 156.0 | Chinese|Others | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex|Ethnicity | Plasma samples|Temperature |Heart rate| Respiratory rate | Diastolic blood pressure | Systolic blood pressure| Oxygen saturation | Haemoglobin|Haematocrit|Platelets|White blood cells|Lymphocytes|Neutrophils|Monocytes|C-reactive protein (CRP)|Creatinine|Lactate dehydrogenase| Alanine aminotransferase (ALT) | Diabetes|Hypertension|Others | NaN | NaN | IgG | Structured |
| PMID:32819220 | https://doi.org/10.1080/22221751.2020.1813636 | NaN | Netherlands | NLD | Longitudinal | 330.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Severity of diseases|Recent other influenza-like illness infection | IgG|Microarray|Virus neutralization test 50 | NaN | NaN | NaN | IgG |Micro-array titres | Structured |
| PMID:33091042 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580996/# | NaN | Korea | KOR | Longitudinal | 154.0 | Korean|Polish | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Symptoms|Symptom onset | Time kinetics for IgG and IgM antibodies | NaN | NaN | Cyclic enhanced fluorescence assay | IgM|IgG | Structured |
| PMID:33199310 | https://bjgpopen.org/content/5/1/bjgpopen20X101137/tab-figures-data | CEIID200406001 | Chile | CHL | Longitudinal | 522.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Nasopharyngeal swabs | IgG|IgM | High blood pressure|Diabetes|Asthma or COPD|Cardiovascular disease|Cancer|Smoking| Symptoms | ARBs|ACE inhibitors|NSAIDSs|Oral steroids|Inhalator steroids | NaN | IgG|IgM | Structured |
| PMID:33388574 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836402/#bib0005 | NaN | Italy | ITA | Longitudinal | 55.0 | NaN | Clinical|Demographic|Laboratory | NaN | Only patients with known date of symptoms’ onset were considered. | Age|Sex | Serum samples|Disease severity|Days from symptom onset|Symptoms| Number of withdrawals per patient | IgG | NaN | NaN | Two-step chemiluminescence micropar-ticle immunoassays | IgG | Structured |
| PMID:33052354 | https://jcm.asm.org/content/59/2/e02489-20/figures-only | RSRB STUDY00004836 | USA | USA | Longitudinal | 140.0 | NaN | Clinical|Demographic|Laboratory | NaN | NaN | Age|Sex | Serum samples|Estimated date of symptom onset|Days of hospitalization|Intensive care unit [ICU] admission|Death|Symptoms | IgG | History of smoking|Coronary artery disease|Chronicobstructive pulmonary disease [COPD]|Diabetes | NaN | Fluorescence | IgG | Structured |
| PMID:33322150 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764094/pdf/ijerph-17-09324.pdf | NaN | Italy | ITA | Longitudinal | 242.0 | NaN | Clinical|Laboratory | NaN | Hospital healthcare workers | NaN | Serum samples | IgG|IgM | NaN | NaN | NaN | IgG|IgM | Structured |
| PMID:33388575 | https://pubmed.ncbi.nlm.nih.gov/33388575/ | NaN | USA | USA | Longitudinal | 89.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | IgM|IgG|Day of seroconversion caught | NaN | NaN | NaN | Survived|Deceased|Immune competent|Immune compromised | Structured |
| PMID:33340166 | https://pubmed.ncbi.nlm.nih.gov/33340166/ | NaN | China | CHN | Longitudinal | 54.0 | NaN | Laboratory | NaN | NaN | NaN | NaN | IgM|IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:33533813 | https://pubmed.ncbi.nlm.nih.gov/33533813/ | NaN | Brazil | BRA | Longitudinal | 209.0 | White|Non white | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | Katz index|Frail-BR index|Frail-NH index|Complexity of the Long Term Care Facility | NaN | NaN | NaN | NaN | Structured |
| PMID:32638712 | https://pubmed.ncbi.nlm.nih.gov/32638712/ | NaN | UK | GBR | Longitudinal | 74.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | IgM|IgA|IgG | NaN | NaN | NaN | Death|Discharged | Structured |
| PMID:33139422 | https://pubmed.ncbi.nlm.nih.gov/33052354/ | NaN | USA | USA|CHE | Longitudinal | 140.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | Spike Median fluorescent intensity (MFI)| Receptor Binding Domain (RBD) Median fluorescent intensity (MFI)|Nucleocapsid Median fluorescent intensity (MFI) | Asthma|COPD|Diabetes|Hypertension|Obstructive sleep apnea|Coronary artery disease|Cerebrovascular disease|Immunodeficiency / Immunosuppression | NaN | NaN | NaN | Structured |
| PMID:33404891 | https://pubmed.ncbi.nlm.nih.gov/33404891/ | NaN | Estonia | EST | Longitudinal | 100.0 | NaN | Laboratory|Demographic | NaN | Availability of leftover sera obtained for routine SARS-CoV-2 serological testing | Age|Sex | NaN | C-Reactive Protein|Ferritin|Dimer-D|Lactose dehydrogenase|Interleukin-6|Total lymphocyte count | Arterial Hypertension|Chronic renal disease|Diabetes|Dyslipidemia|Ischemic cardiovascular disease|Myocardial infarction|Pulmonary disease|Tumor | NaN | NaN | NaN | Structured |
| PMID:33555331 | https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776019 | NaN | USA | USA | Cross-sectional | 4675.0 | Hispanic|Non Hispanic | NaN | NaN | NaN | Age|Sex | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| PMID:33557402 | https://pubmed.ncbi.nlm.nih.gov/33557402/ | ISRCTN91064601 | Italy | ITA | Longitudinal | 84.0 | NaN | Laboratory|Demographic | NaN | Age between 4 and 16 with at least one cohabitant who had been positive for SARS-CoV-2 | Age|Sex | NaN | IgM|IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:33608522 | https://www.nature.com/articles/s41467-021-21444-5 | NaN | Australia | AUS | Longtitudinal | 64.0 | NaN | Laboratory|Demographic | NaN | NaN | NaN | NaN | IgM|IgG |IgA | NaN | NaN | NaN | NaN | Structured |
| PMID:33664294 | https://www.nature.com/articles/s41598-021-84387-3 | NaN | Japan | JPN | Longitudinal | 500.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | N-IgG|S-IgG|N-IgM|S-IgM | NaN | NaN | NaN | NaN | Structured |
| PMID:33553482 | https://academic.oup.com/ofid/article/8/2/ofaa654/6116757 | NaN | USA | USA|CHE | Longitudinal | 432.0 | Black|White|Hispanic|Other | Laboratory | NaN | NaN | NaN | NaN | Spike IgG|Spike IgM|RBD IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:33680466 | https://onlinelibrary.wiley.com/doi/full/10.1002/cti2.1258 | NaN | NaN | NaN | Longitudinal | 15.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | Receptor Binding Domain IgM |Spike IgG|Spike IgA|Nucleocapsid IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:33169014 | https://www.nature.com/articles/s41590-020-00828-7 | NaN | USA | USA | Longitudinal | 43.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | IgM|IgA|IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:32856707 | https://pubmed.ncbi.nlm.nih.gov/32856707/ | NaN | China | CHN | Longitudinal | 100.0 | Chinese | Laboratory|Demographic|Clinical | NaN | Patients confirmed to have COVID-19 by SARS-CoV-2 (RT-PCR) and admitted to any of seven public hospitals in Singapore | Age|Sex | Temperature|Respiratory rate|Heart rate|Systolic blood pressure|Pulse oximeter oxygen saturation | Haemoglobin|Platelet|Lymphocyte|Neutrophil|C-Reactive Protein|Lactate dehydrogenase|Creatinine|Alanine transferase|PCR Ct value at diagnosis | Diabetes|Hypertension | NaN | NaN | NaN | Structured |
| PMID:32991844 | https://www.sciencedirect.com/science/article/abs/pii/S0092867420312344 | NaN | Italy|Switzerland|US | ITA|CHE|USA | Longitudinal | 647.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | Serum IgG binding to S|Serum IgG binding to RBD|Serum IgG binding to N | NaN | NaN | NaN | NaN | Structured |
| PMID:32727884 | https://immunology.sciencemag.org/content/5/49/eabd5709 | NaN | USA | USA | Longitudinal | 1293.0 | Black/Non-Hispanic|White/Non-Hispanic|Hispanic/Latino|Asian|Other/Unknown | Laboratory|Demographic | NaN | NaN | Age |Sex | NaN | IgG|IgM | Obesity|Diabetes|Hypertension|Diabetes|Asthma | NaN | NaN | NaN | Structured |
| PMID:32511324 | https://www.biorxiv.org/content/10.1101/2020.03.24.006544v1 | NaN | USA | USA | Longitudinal | NaN | NaN | Laboratory | NaN | NaN | NaN | NaN | IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:32938700 | https://msphere.asm.org/content/5/5/e00802-20 | NaN | USA | USA | Longitudinal | NaN | NaN | NaN | NaN | NaN | NaN | NaN | RBD-biotin|RBD-hFc| RBD-mFc | NaN | NaN | NaN | NaN | Unstructured |
| PMID:33227020 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682882/ | NaN | Israel | ISR | Longitudinal | 309.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | IgM|IgG|IgA | NaN | NaN | NaN | NaN | Structured |
| PMID:32908997 | https://www.medrxiv.org/content/10.1101/2020.09.04.20187088v1 | NaN | USA | USA | Longitudinal | 159.0 | NaN | Laboratory | NaN | Patients without asymptomatic individuals or patients with mild symptoms infected with SARS-CoV-2 | Age|Sex | NaN | NaN | NaN | NaN | NaN | Alive|Dead | Structured |
| PMID:33232382 | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242917 | NaN | Germany | DEU | Longitudinal | 23.0 | NaN | Laboratory|Demographic | NaN | Age greater than equal to 18 with a confirmed diagnosis of COVID-19 | Age|Sex|BMI | NaN | PaO2/FiO2|Extracorporeal membrane oxygenation(ECMO) | Chronic obstructive pulmonary disease|Arterial hypertension|Coronary artery disease|Diabetes mellitus|Chronic renal insufficiency | NaN | NaN | NaN | Structured |
| PMID:33233405 | https://pubmed.ncbi.nlm.nih.gov/33233405/ | NaN | Belgium | BEL | Longitudinal | 94.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | N-directed IgG|S1-directed IgG|S2-directed IgG|RBD-directed IgG | NaN | NaN | NaN | NaN | Structured |
| PMID:33755731 | https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab161/6184123 | NaN | USA | USA|CHE | Longitudinal | 3418.0 | NaN | Laboratory | NaN | NaN | Age | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| PMID:32306864 | https://pubmed.ncbi.nlm.nih.gov/32306864/ | NaN | China | CHN | Longitudinal | 21.0 | NaN | Laboratory|Demographic | NaN | NaN | Age|Sex | NaN | Anti SARS-CoV-2 IgG|Anti SARS-CoV-2 IgM | NaN | NaN | NaN | NaN | Structured |
| PMID:32476258 | https://pubmed.ncbi.nlm.nih.gov/32476258/ | NaN | USA | USA | Longitudinal | 9.0 | Black|Latino|Asian|NH/PI|White | Laboratory|Demographic|Clinical | NaN | NaN | Age|Sex|BMI | Temperature | WBC count|Lymphocyte|Platelets|Creatinine|Aspartate aminotransferase|Alanine aminotransferase|Troponin|C-Reactive Protein|Lactate dehydrogenase|Procalcitonin|D-Dimer | Cerebrovascular disease|Continuous renal replacement therapy|Deceased donor renal transplant|Diabetes mellitus|Ground-glass opacities|Hyperlipedimia|Hypertension|Asthma|Dementia|Hypothyroid|Sarcoidosis|Gout|Heart failure with reduced ejection fraction|Upper respiratory symptoms|Rheumatoid arthritis | Hydroxychloroquine|Lopinavir/ritonavir| | CT scan | Discharged ICU|Discharged hospital|Died | Structured |
| PMID:33161369 | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590643/ | NaN | USA | USA | Longitudinal | 427.0 | NaN | Laboratory|Demographic | NaN | NaN | Age | NaN | IgM|IgG | NaN | NaN | NaN | NaN | Structured |